Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry
- PMID: 37067605
- DOI: 10.1007/s00520-023-07687-6
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry
Abstract
Purpose: Preventing chemotherapy-induced alopecia (CIA) is related to the degree of temperature reduction during scalp cooling. Wetting hair before scalp cooling reduces the scalp skin temperature. This observational study investigated the effects of wetting hair before scalp cooling on preventing CIA and on tolerance in cancer patients.
Methods: This Dutch multi-center cohort study comprised 1825 patients receiving ≥1 cycle of docetaxel (D), 5-fluorouracil-epirubicin-cyclophosphamide (FEC), 5-fluorouracil-epirubicin-cyclophosphamide-docetaxel (FECD), paclitaxel (P), or paclitaxel-carboplatin (PC). Patients underwent scalp cooling with wet or dry hair. Primary and secondary outcomes were the effects of wetting hair on head cover use and tolerance, respectively.
Results: None of the associations between wetting hair and head cover use in patients on D, FEC, P, or PC was significant; however, results all tended to be in favor of wetting hair. For FECD, univariate (p=0.005; OR=1.6; CI=1.1-2.1) and multivariable associations (p=0.007; OR=1.8; CI=1.2-2.6) were significant. Scalp cooling discontinuation due to intolerance differed significantly between groups that wetted hair or not (3% and 1% respectively; p=0.034).
Conclusion: In a large patient group with mainly a European hair type and a high hair mass, no convincing evidence was found whether wetting hair prior to scalp cooling contributes to better prevention of CIA. Since it is argued that a higher reduction in scalp skin temperature by wetting hair contributes positively to scalp cooling efficacy, only a randomized controlled trial can provide an ultimate conclusion at the highest level of evidence. Until that time, healthcare professionals have to take into account that wetting hair may introduce lower compliance to the scalp cooling procedure.
Keywords: Alopecia; Chemotherapy; Hair preservation; Scalp cooling; Tolerance; Wetting hair.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.Support Care Cancer. 2019 May;27(5):1919-1925. doi: 10.1007/s00520-018-4432-6. Epub 2018 Sep 11. Support Care Cancer. 2019. PMID: 30206728 Clinical Trial.
-
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.Clin Breast Cancer. 2015 Oct;15(5):332-4. doi: 10.1016/j.clbc.2015.01.003. Epub 2015 Jan 26. Clin Breast Cancer. 2015. PMID: 25749072
-
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.Support Care Cancer. 2022 Aug;30(8):6641-6648. doi: 10.1007/s00520-022-07090-7. Epub 2022 May 2. Support Care Cancer. 2022. PMID: 35501515 Free PMC article. Clinical Trial.
-
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.Eur J Cancer. 1994;30A(10):1448-53. doi: 10.1016/0959-8049(94)00280-i. Eur J Cancer. 1994. PMID: 7833100 Review.
-
A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.Oncologist. 2018 Jan;23(1):84-96. doi: 10.1634/theoncologist.2017-0263. Epub 2017 Sep 26. Oncologist. 2018. PMID: 28951499 Free PMC article. Review.
Cited by
-
Analysis of risk factors for postoperative thrombosis in patients with hematological diseases undergoing PICC surgery.Medicine (Baltimore). 2025 Jan 10;104(2):e41181. doi: 10.1097/MD.0000000000041181. Medicine (Baltimore). 2025. PMID: 39792736 Free PMC article.
-
Shorter post-infusion cooling times at least as effective as longer cooling times - An observational study of taxane- and anthracycline-based chemotherapies in the Dutch Scalp Cooling Registry.Support Care Cancer. 2025 May 28;33(6):503. doi: 10.1007/s00520-025-09526-2. Support Care Cancer. 2025. PMID: 40434428
-
Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study.Sci Rep. 2023 Nov 9;13(1):19555. doi: 10.1038/s41598-023-46840-3. Sci Rep. 2023. PMID: 37945813 Free PMC article. Clinical Trial.
References
-
- Komen MMC (2020) Clinical aspects of scalp cooling in chemotherapy induced alopecia. Dissertation, University of Leiden
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical